Genes of major histocompatibility complex class II influence chronic C hepatitis treatment with interferon in hemodialysis patients

International Journal of Artificial Organs

Volumn 24, Issue 4, 2001, Pages 212-214

  Dincer D ^a   Besisik, F ^a   Oguz F ^a   Sukru Sever M ^a   Kaymakoglu, S ^a   Cakaloglu Y ^a   Demir, K ^a   Turkoglu S ^a   Carin M ^a   Okten, A ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Hemodialysis; HLA; Interferon

Indexed keywords

ANTIBIOTICS; C (PROGRAMMING LANGUAGE); DIALYSIS; GLYCOPROTEINS; HEMODIALYZERS; PATIENT TREATMENT;

CLASS II; GENERAL POPULATION; HAEMODIALYSIS; HEMODIALYSIS PATIENT; HLA; INTERFERON; INTERFERON ALFA; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS; MEAN AGES; UREMIC PATIENTS;

GENES;

ALPHA2B INTERFERON; HEPATITIS C ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HLA MATCHING; HOST PARASITE INTERACTION; HUMAN; MALE; NONHUMAN; POPULATION RESEARCH; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; UREMIA; VIRUS GENOME;

EID: 0035006931     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880102400408     Document Type: Article

References (19)